NBS approaches to the approval of suppliers of leucodepletion systems.
Smith
K J
KJ
NBS London and South East, UK.
D001771:Blood Banks / Q000592:standards*; D001781:Blood Component Removal / Q000295:instrumentation; D016913:Blood Component Transfusion / Q000592:standards*; D002469:Cell Separation / Q000295:instrumentation*; D003284:Contract Services; D007562:Creutzfeldt-Jakob Syndrome / Q000517:prevention & control / Q000635:transmission; D018795:Device Approval; D005374:Filtration / Q000295:instrumentation*; D006801:Humans; D007962:Leukocytes / Q000737:chemistry; D009313:National Health Programs; D011785:Quality Assurance, Health Care; D012449:Safety; D065227:Transfusion Reaction; D006113:United Kingdom